logo
logo

AI Health Tech Start-up Infermedica Raises $10 Million Series A for R&D and International Expansion – Customers Include Microsoft

Aug 06, 2020•almost 5 years ago

Amount Raised

$10 Million

Round Type

series a

Denver

Description

Infermedica, the AI-based platform for preliminary diagnosis and triage, announced it has raised $10.25 million in Series A funding. The round was led by the European Bank for Reconstruction and Development (EBRD) and digital health fund Heal Capital, with participation from existing investors Karma Ventures, Inovo Venture Partners, and Dreamit Ventures.

Company Information

Company

Infermedica

Location

Denver, Colorado, United States

About

Infermedica is a leading digital health company, specializing in AI-powered solutions for symptom analysis and patient triage. The company's mission is to make healthcare accessible, convenient and affordable for everyone worldwide, by automating primary care, from symptom to outcome. Infermedica has been adeptly interweaving medical and technical expertise into their technologies since 2012, to support industry leaders including Allianz, Global Excel, Gothaer, Microsoft, Optum, and Sana Kliniken. Infermedica is now being used in more than 30 countries, in 19 languages, and has completed more than 10 million successful health checks to date. To learn more, visit www.infermedica.com

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People